Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration.

Saved in:
Bibliographic Details
Title: Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration.
Authors: Lanzetta P; Department of Medicine-Ophthalmology, University of Udine, and Istituto Europeo di Microchirurgia Oculare-IEMO, Udine-Milan, Italy., Korobelnik JF; CHU Bordeaux, Service d'Ophtalmologie, Bordeaux, France.; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France., Heier JS; Ophthalmic Consultants of Boston, Boston, MA, USA., Leal S; Bayer Consumer Care AG, Basel, Switzerland., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany., Clark WL; Palmetto Retina Center, West Columbia, SC, USA., Eichenbaum D; Retina Vitreous Associates of Florida, Tampa, FL, USA., Iida T; Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan., Sun X; Shanghai General Hospital, Shanghai, China., Berliner AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Schulze A; Bayer AG, Berlin, Germany., Schmelter T; Bayer AG, Berlin, Germany., Schmidt-Ott U; Bayer AG, Berlin, Germany., Zhang X; Bayer Consumer Care AG, Basel, Switzerland., Vitti R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Chu KW; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Reed K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Rao R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Bhore R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Cheng Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Wong TY; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, and Tsinghua Medicine, Tsinghua University, Beijing, China.
Source: Therapeutic advances in ophthalmology [Ther Adv Ophthalmol] 2025 Aug 18; Vol. 17, pp. 25158414251356388. Date of Electronic Publication: 2025 Aug 18 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Sage Publications Ltd Country of Publication: United States NLM ID: 101728805 Publication Model: eCollection Cited Medium: Internet ISSN: 2515-8414 (Electronic) Linking ISSN: 25158414 NLM ISO Abbreviation: Ther Adv Ophthalmol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2515-8414
DOI:10.1177/25158414251356388